Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Drugs - Real World Outcomes|March 14, 2025
Long-Term Evaluation of Effectiveness and Immunological Implications of Ocrelizumab in a Real-World CohortTommaso Guerra, Francesca Caputo, Antonella Bianco, et al.
Clinical Neurology and Neurosurgery|August 19, 2024
Siponimod from fingolimod direct switch in patients transitioning in secondary progressive multiple sclerosis: A single center case seriesAntonella Bianco, Tommaso Guerra, Francesca Caputo, et al.
La Medicina Del Lavoro|November 9, 2005
[Radiological and functional progression in silicosis]N L'Abbate, Carmelina Di Pierri, Alda Nuzzaco, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|March 7, 2021
Long-term comparative analysis of no evidence of disease activity (NEDA-3) status between multiple sclerosis patients treated with natalizumab and fingolimod for up to 4 yearsTommaso Guerra, Francesca Caputo, Bianca Orlando, et al.
Clinical Neurology and Neurosurgery|August 21, 2021
Guillain-Barré syndrome after AstraZeneca COVID-19-vaccination: A causal or casual association?Alessandro Introna, Francesca Caputo, Carlo Santoro, et al.
Future Oncology (London, England)|August 4, 2015
Response to eribulin in a difficult-to-treat, heavily pretreated breast cancer patient: a case reportLuigi Leo, Francesca Caputo, Antonella Di Sarno, et al.
Life (Basel, Switzerland)|October 28, 2023
Multimodality Cardiovascular Imaging of Cardiotoxicity Due to Cancer TherapyCarla Contaldi, Vincenzo Montesarchio, Dario Catapano, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|February 11, 2026
Refining predictors of long-term NEDA-3 status in relapsing-remitting multiple sclerosis: insights from real-world dataTommaso Guerra, Antonella Bianco, Chiara Esposto, et al.
BMC Psychology|July 29, 2025
The protective role of cognitive reserve in moderating depressive symptomatology in patients with multiple sclerosisMadia M Biasi, Paolo Taurisano, Alessia Manni, et al.
Pageof 3